{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:43Z","timestamp":1786991563273,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2634-F-A49-005"],"award-info":[{"award-number":["110-2634-F-A49-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-075A-010"],"award-info":[{"award-number":["110-2314-B-075A-010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 111-2218-E-039-001"],"award-info":[{"award-number":["NSTC 111-2218-E-039-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1117302D"],"award-info":[{"award-number":["TCVGH-1117302D"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-YM1110107"],"award-info":[{"award-number":["TCVGH-YM1110107"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1117306C"],"award-info":[{"award-number":["TCVGH-1117306C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["VTA111-V2-1-1"],"award-info":[{"award-number":["VTA111-V2-1-1"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbspin.2025.105990","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:01:34Z","timestamp":1760803294000},"page":"105990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of drug-drug interaction of JAK inhibitors, CYP enzyme inhibitors and OAT3 inhibitors on persistence and infection rates in patients with autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"93","author":[{"given":"Yu-Hsuan Joni","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Tung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Mao","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3065","authenticated-orcid":false,"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10055","key":"10.1016\/j.jbspin.2025.105990_bib0110","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jbspin.2025.105990_bib0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2025.105990_bib0120","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105990_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105990_bib0130","series-title":"Xeljanz (tofacitinib) [package insert]","year":"2019"},{"key":"10.1016\/j.jbspin.2025.105990_bib0135","series-title":"Rinvoq (upadacitinib) [package insert]","year":"2021"},{"key":"10.1016\/j.jbspin.2025.105990_bib0140","doi-asserted-by":"crossref","first-page":"116421","DOI":"10.1016\/j.biopha.2024.116421","article-title":"CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism","volume":"175","author":"Ye","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jbspin.2025.105990_bib0145","series-title":"Olumiant (baricitinib) [package insert]","year":"2019"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105990_bib0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40744-020-00275-8","article-title":"Frequency of prescription claims for drugs that may interact with Janus kinase inhibitors among patients with rheumatoid arthritis in the US","volume":"8","author":"Walton","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"Database issue","key":"10.1016\/j.jbspin.2025.105990_bib0155","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jbspin.2025.105990_bib0160","doi-asserted-by":"crossref","first-page":"104392","DOI":"10.1016\/j.phrs.2019.104392","article-title":"The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors","volume":"147","author":"Bechman","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jbspin.2025.105990_bib0165","first-page":"81","article-title":"Clopidogrel use and CYP2C19 genotypes in patients undergoing vascular intervention procedure: a hospital-based study","volume":"15","author":"Liao","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105990_bib0170","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1038\/s41467-025-61644-x","article-title":"Clinical impact of pharmacogenetic risk variants in a large chinese cohort","volume":"16","author":"Wei","year":"2025","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jbspin.2025.105990_bib0175","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.113.054940","article-title":"The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans","volume":"42","author":"Dowty","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.jbspin.2025.105990_bib0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","article-title":"The emerging safety profile of JAK inhibitors in rheumatic disease","volume":"13","author":"Winthrop","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.jbspin.2025.105990_bib0185","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40262-017-0605-6","article-title":"Population pharmacokinetics of upadacitinib in healthy subjects and subjects with rheumatoid arthritis: analyses of phase I and II clinical trials","volume":"57","author":"Kl\u00fcnder","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105990_bib0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-019-1964-1","article-title":"Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations","volume":"21","author":"McInnes","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.jbspin.2025.105990_bib0195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.201206-1063PP","article-title":"Respiratory infection and the impact of pulmonary immunity on lung health and disease","volume":"186","author":"Mizgerd","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105990_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2025.105990_bib0205","unstructured":"Cytochrome P450 drug interaction table n.d. https:\/\/drug-interactions.medicine.iu.edu\/MainTable.aspx (accessed July 29, 2025)."},{"key":"10.1016\/j.jbspin.2025.105990_bib0210","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.3712","article-title":"Evaluating the evidence for CYP2C19\u00a0inhibitor classifications: a scoping review","author":"Malav\u00e9","year":"2025","journal-title":"Clin Pharmacol Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:01:23Z","timestamp":1772568083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X25001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1297319X25001526"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105990","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of drug-drug interaction of JAK inhibitors, CYP enzyme inhibitors and OAT3 inhibitors on persistence and infection rates in patients with autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105990"}}